Business
American Premium Water Corp (OTC: HIPH) Could Potentially Surge More Than 600% Based on Recent Price Targets and Financing Agreements
American Premium Water Corp (OTC: HIPH) Could Potentially Surge More Than 600% Based on Recent Price Targets and Financing Agreements.
About this update from American Premium Water Corporation
[{"type":"text","content":"\nNEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- SmallCapTips Commentary –\n American Premium Water Corporation (OTC:HIPH) rallied last year over 1000%, and is now sitting below its prior resistance levels. The stock has been trending upward lately, and if HIPH were to break through its January highs, it will signal potentially another wave were it will reach higher values, so short-term traders could look for a break above the key resistance levels for an entry point. Normally this kind of bounce back is seen as a short-term turning point. The stock price, which closed last week at $0.0609, is trading above its 50 and 200-day moving averages, which has historically indicated a bullish trend for the medium and long-term.  HIPH has been making higher top and higher bottoms within the past 20 trading days with the daily volume rising over the same period, which is indicated on its daily chart. Evaluating the qualitative factors of the Company’s business, HIPH recently announced an acquisition of a CBD cosmetics brand plant + body and a CBD vape brand Evoxe Laboratories. The Company has been focusing on acquisitions in the CBD space to compliment their CBD infused water business. HIPH has proprietary ‘hydro-nano’ formulations that utilize nano-technology that increases the CBD’s bioavailability, which increases the rate of absorption into the bloodstream. SmallCap Tips is bullish on their focus on CBD technology and believes the technical indicators are coming in line with the moves that the Company has been making.    Recent Research Highlights SeeThru Equity, the leading small and microcap research firm, recently upgraded its price target for HIPH from $0.15 to $0.30Ludlow Research recently provided a short, speculative price target for the Company of $0.15-$0.20 a shareThe Company recently entered into a financing agreement that gave it a $0.40 valuationZacks Investment Research has a neutral view of the CompanyBarchart currently gives the Company a “Buy” rating For commentary inquiries, please contact: [email protected] This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are mad...